ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,562.57
0.24%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cingulate Inc (CINGW)

  7. Cingulate Inc (CINGW) News

CINGW Cingulate Inc

0.015
0.00 (0.00%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cingulate Inc CINGW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.015 06:00:02
Open Price Low Price High Price Close Price Previous Close
0.015 0.015 0.015 0.015 0.015
more quote information »

Recent News

Date Time Source Heading
17/4/202407:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202423:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202407:45GLOBECingulate to Participate in Benzinga All Live Access Event
06/3/202422:45GLOBECingulate to Attend DCAT Week 2024 in New York City
13/2/202422:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
07/2/202408:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
03/2/202401:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
30/1/202400:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202422:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
02/12/202301:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
14/11/202308:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
18/10/202305:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
22/9/202303:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
14/9/202306:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
11/9/202323:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
11/9/202320:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
09/9/202306:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
05/9/202322:00GLOBECingulate Announces Presentation of Full Trial Results from..
15/8/202306:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
11/7/202322:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
29/6/202322:00GLOBECingulate Successfully Manufactures Clinical Supply –..
15/6/202305:45GLOBECingulate to Participate in the Healthcare Virtual..
08/6/202321:00GLOBECingulate Completes Phase 3 Adult Trial of CTx-1301..
26/5/202305:55GLOBECingulate to Present at 13th Annual LD Micro Invitational
13/5/202305:45GLOBECingulate, Indegene to Participate in Benzinga All Live..
11/5/202306:15GLOBECingulate Inc. Reports First Quarter 2023 Financial Results..
03/5/202320:45GLOBECingulate Announces Successful Transfer of CTx-1301..

Your Recent History

NASDAQ
CINGW
Cingulate
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved